TY  - JOUR
AU  - Herrero-Morant, Alba
AU  - Álvarez-Reguera, Carmen
AU  - Martín-Varillas, José L
AU  - Calvo-Río, Vanesa
AU  - Casado, Alfonso
AU  - Prieto-Peña, Diana
AU  - Atienza-Mateo, Belén
AU  - Maiz-Alonso, Olga
AU  - Blanco, Ana
AU  - Vicente, Esther
AU  - Rúa-Figueroa, Íñigo
AU  - Cáceres-Martin, Laura
AU  - García-Serrano, José L
AU  - Callejas-Rubio, José Luis
AU  - Ortego-Centeno, Norberto
AU  - Narváez, Javier
AU  - Romero-Yuste, Susana
AU  - Sánchez, Julio
AU  - Estrada, Paula
AU  - Demetrio-Pablo, Rosalía
AU  - Martínez-López, David
AU  - Castañeda, Santos
AU  - Hernández, José L
AU  - González-Gay, Miguel Á
AU  - Blanco, Ricardo
PY  - 2020
DO  - 10.3390/jcm9082608
SN  - 2077-0383
UR  - https://hdl.handle.net/10668/26015
T2  - Journal of clinical medicine
AB  - We aimed to assess the efficacy of biologic therapy in refractory non-Multiple Sclerosis (MS) Optic Neuritis (ON), a condition more infrequent, chronic and severe than MS ON. This was an open-label multicenter study of patients with non-MS ON...
LA  - en
KW  - adalimumab
KW  - biologic therapy
KW  - infliximab
KW  - optic neuritis
KW  - rituximab
KW  - tocilizumab
TI  - Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
TY  - research article
VL  - 9
ER  -